Medikaloka Hermina PT (HEAL) — Cash Flow Quality Index
Medikaloka Hermina PT (HEAL) has a Cash Flow Quality Index of 2.25x as of June 2025. Operating cash flow of Rp225.37 Billion exceeds net income of Rp100.12 Billion, indicating high earnings quality where cash backs reported profits. Explore HEAL operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Medikaloka Hermina PT Cash Flow Quality Index (2015–2024)
Historical Cash Flow Quality Index for Medikaloka Hermina PT across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check HEAL total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Medikaloka Hermina PT (2015–2024)
Year-by-year earnings quality comparison for Medikaloka Hermina PT. For live market cap and the full company financial profile, see Medikaloka Hermina PT (HEAL) total market value.
| Year | Quality Index | Operating CF (IDR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.12x | Rp1.14 Trillion | Rp535.94 Billion | ▼ -29.7% |
| 2023 | 3.02x | Rp1.32 Trillion | Rp437.35 Billion | ▲ +127.0% |
| 2022 | 1.33x | Rp503.58 Billion | Rp378.77 Billion | ▼ -28.7% |
| 2021 | 1.86x | Rp1.86 Trillion | Rp995.97 Billion | ▼ -21.7% |
| 2020 | 2.38x | Rp1.13 Trillion | Rp473.22 Billion | ▲ +6.2% |
| 2019 | 2.24x | Rp572.58 Billion | Rp255.37 Billion | ▲ +15.4% |
| 2018 | 1.94x | Rp241.67 Billion | Rp124.37 Billion | ▼ -59.2% |
| 2017 | 4.77x | Rp465.08 Billion | Rp97.55 Billion | ▼ -18.5% |
| 2016 | 5.85x | Rp362.85 Billion | Rp62.00 Billion | ▼ -55.8% |
| 2015 | 13.25x | Rp255.71 Billion | Rp19.30 Billion | — |